You just read:

Heptares and PeptiDream Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Therapeutics in Inflammatory Disease

News provided by

Heptares Therapeutics and PeptiDream

29 Jun, 2017, 08:00 BST